Croup Clinical Trial
Official title:
A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice
Verified date | September 2005 |
Source | University of Calgary |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
The purpose of this study is to identify, from a societal perspective, the costs and associated benefits of three strategies for disseminating and implementing a practice guideline that addresses the management of croup.
Status | Terminated |
Enrollment | 0 |
Est. completion date | March 2006 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Alberta hospitals were rank ordered based on the number of disease episodes and rates of hospitalization for a six-year period. We then approached in this order each of the hospital administrators and clinical staff for permission to include their hospital in our study until a total of 24 hospitals consented Exclusion Criteria: - Refusal by hospital staff to participate in this trial |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Canadian Institutes of Health Research (CIHR) |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of hospital days per 1,000 disease episodes | |||
Secondary | Proportion of patients treated in the ED and hospital with a corticosteroid. | |||
Secondary | Proportion of patients evaluated in ED for at least three hours after treatment with corticosteroids before the decision to admit to hospital is made. | |||
Secondary | Time to treatment with corticosteroids in both ED and hospital patients. | |||
Secondary | An economic analysis conducted from a societal perspective with costs classified as either payer (costs born by the province) or non-payer (costs born by individuals or the families of children with croup). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01748162 -
Management of Recurrent Croup
|
Phase 3 | |
Completed |
NCT00230841 -
Comparing Different Ways of Delivering Humidity to Children With Croup
|
Phase 2 | |
Terminated |
NCT03705273 -
Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup
|
Phase 4 | |
Completed |
NCT01042145 -
Community Care for Croup (RCT)
|
Phase 4 | |
Completed |
NCT00368823 -
A Trial of Point of Care Information in Ambulatory Pediatrics
|
Phase 3 | |
Completed |
NCT05668364 -
Impact of Cold Air Exposure on Croup Symptoms
|
N/A | |
Not yet recruiting |
NCT06272383 -
Croup Dosing Study
|
Phase 1 | |
Completed |
NCT03392363 -
Diagnosing Respiratory Disease in Children Using Cough Sounds 2
|
||
Recruiting |
NCT01664507 -
The Effect and Safety of Low Dose Nebulized Epinephrine in Croup
|
Phase 4 | |
Completed |
NCT06156436 -
A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department
|
||
Not yet recruiting |
NCT04168554 -
Telemedicine in the Generals Practitioners Office
|
||
Completed |
NCT02973282 -
Diagnosing Respiratory Disease in Children Using Cough Sounds
|
N/A | |
Terminated |
NCT00938353 -
Efficacy of Nebulized Beclomethasone Dipropionate (BDP) in the Treatment of Moderate Croup
|
Phase 3 |